activated in Streptomyces olivaceus SCSIO T05, enabling the discovery of mycemycin C (4)
and three new analogues [mycemycins F–H (1–3)]. Gene disruption, complementation
experiments, and enzymatic assays unveiled salicylic acid and 5-Cl-kynurenine as
biosynthetic precursors and shed significant functional insights into MycO, MycB, MycR, and
MycJ, enzymes responsible for fine-tuning of the DBP scaffold.